However, limited by the in vivo and in vitro models we used, the function of circLHFPL2 on regulating MEK inhibitor in the treatment of CRC patients needs to be further investigated from the perspective of clinical treatment in the future. The gene discussed is MAP2K7; the disease is colorectal carcinoma.